Business Wire

BITEPRO

Share
British Firm BitePRO Claim Education Professionals Are Bitten By Pupils On Daily Basis

According to British firm BitePRO , teachers and education professionals are at increased risk of being bitten by pupils and the consequences can be severe.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191015005707/en/

Human bites can more dangerous than animal bites because of the large quantity and types of bacteria and viruses contained in the human mouth. Human bites that break the skin can become severely infected.

According to several medical sources, human bites have been shown to transmit hepatitis B, hepatitis C, herpes simplex virus (HSV) syphilis, tuberculosis, actinomycosis, tetanus and even the human immunodeficiency virus (HIV).

Robert Kaiser, CEO of BitePRO a firm specialised in bite resistant clothing states: “We are fully aware of teachers working in special educational needs schools or units for pupils with severe mental and behavioural problems who were bitten so hard, so they had to be given vaccinations against infectious diseases and viruses such as Hepatitis B. Many also required immediate surgery.”

“Regrettably, there is still a culture in some schools, particularly where pupils have severe behavioural problems, that being assaulted is all part of the job.”

Recently, teachers seem to talk openly about their daily experiences of being bitten, and their visits to hospitals. This is most certainly the case.

Brett Bigham, Oregon’s Teacher of the Year in 2014 reported to have been bitten so badly that he was sent to the hospital.

In October 2019 a Canberra public school worker was repeatedly bitten by one of her students. She was injured on a weekly basis, for six months, by a child with a mental disability. In an interview with local media she stated: “"I was bitten on the arms; I was bitten on the stomach and I was bitten on the leg. That was day one."

The ‘News and Features from the National Education Association’ admitted or rather stated on the 20 June 2019 that many teachers, administrators, and education support professionals (ESPs) are at risk of being bitten while at work.

Educational professionals around the world are now rightly calling for greater protection from children who bite them. Human teeth breaking their skin and leading to serious injury, infections, long term trauma and require complex surgery cannot be part of their daily routine.

Many have now walked away from a profession they were once extremely passionate about, because medical experts have been able to identify that they suffer from PTSD (Post Traumatic Stress Disorder), an illness, usually associated to soldiers returning from wars, having witnessed severe levels of violence.

According to Robert Kaiser, bite resistant arm guards might not change the behaviour of violent children, or the behaviour of children diagnosed with specific mental illnesses. But there is no question about it, such type of highly protective clothing will reduce the risk of injury and infections. It will prevent immense long-term emotional distress to teachers. It will help them to continue working within a sector they are passionate about.

Kayleigh Davis, Senior Consultant at BitePRO is also keen to point out some vital legal information: “Today’s legal environment will require a risk assessment to be conducted, highlighting any realistic risk employees are being exposed to e.g. being bitten by a pupil.”

“The purpose of such is to very clearly identifying a) the precise risk, b) the potential liability and c) the implementation of effective mitigating measures. I believe that BitePRO should be considered as one of many mitigations measures you can utilise and implement to reduce a realistic risk faced by today’s educational professionals.”

“Failing to do so can ultimately result in liability claims and legal action being taken against your organisation by either an injured employee or indeed an overseeing government body.”

The Portland Tribune reported on 01 February 2019 that eight educational assistants are suing Portland Public Schools and several administrators for $3.6 million alleging the special needs students they were supposed to assist frequently assaulted them by biting and scratching etc. The lawsuit accused the district partly of negligence. The lawsuit claimed the district and administrators did not sufficiently protect the educational assistants or students.

The fact of the matter is a school and any other educational facility is required to provide a safe and healthy workplace: It is not optional. It is the law.

For any product related questions, please email info@bite-pro.com .

### END

About BitePRO:

The BitePRO brand is part of PPSS Group’s global operation. PPSS Group is specialised in the development, manufacturing and supply of high-performance personal protective equipment, offering unrivalled protection from edged weapons, blunt force trauma and even human bites. Please follow BitePRO on social media: Facebook , LinkedIn , Twitter and Instagram .

Link:

ClickThru

Social Media:

https://www.facebook.com/biteproclothing/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release

- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and

Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release

The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p

Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release

‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye